Based on the cut-off values determined for MRPL23 mRNA, high expression was observed in 240 (50.53%) ccRCC cases, while low expression was found in 235 (49.47%) cases. This evidence concerns the gene MRPL23 and nonpapillary renal cell carcinoma.